Green tea consumption and the risk of liver cancer in Japan: The Ohsaki Cohort study

Cancer Causes and Control

Volumn 20, Issue 10, 2009, Pages 1939-1945

  Ui, Akane ^a   Kuriyama, Shinichi ^a   Kakizaki, Masako ^a   Sone, Toshimasa ^a   Nakaya, Naoki ^a   Ohmori Matsuda, Kaori ^a   Hozawa, Atsushi ^a   Nishino, Yoshikazu ^b   Tsuji, Ichiro ^a  

^a TOHOKU UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b MIYAGI CANCER CENTER RESEARCH INSTITUTE   (Japan)

Author keywords

Green tea; Incidence; Japanese; Liver cancer

Indexed keywords

ADULT; AGE DISTRIBUTION; AGED; ARTICLE; CANCER INCIDENCE; CANCER RISK; COFFEE; DAIRY PRODUCT; DISEASE ASSOCIATION; DRINKING BEHAVIOR; FEMALE; FISH; FOLLOW UP; FOOD INTAKE; FRUIT; HUMAN; JAPAN; JAPANESE; LIVER CANCER; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROSPECTIVE STUDY; SMOKING; SOYBEAN; TEA; VEGETABLE;

ADULT; AGED; BEVERAGES; CARCINOMA; COHORT STUDIES; DRINKING BEHAVIOR; EATING; FEMALE; HUMANS; INCIDENCE; JAPAN; LIVER NEOPLASMS; MALE; MIDDLE AGED; NUTRITION SURVEYS; RISK FACTORS; TEA;

EID: 71349088634     PISSN: 09575243     EISSN: 15737225     Source Type: Journal    
DOI: 10.1007/s10552-009-9388-x     Document Type: Article

References (29)

1. R Lamber S Franceschi 2007 Hepatocellular carcinoma World Gastroenterol News 12 23 29
2. F Lodato G Mazzella D Festi F Azzaroli A Colecchia E Roda 2006 Hepatocellular carcinoma prevention: a worldwide emergence between the opulence of developed countries and the economic constraints of developing nations World J Gastroenterol 12 7239 7249 17143937
3. Kakuta Y, Nakaya N, Nagase S, et al. (2009) Case-control study of green tea consumption and the risk of endometrial endometrioid adenocarcinoma. Cancer Causes Control 20:617-624
4. YC Kuo CL Yu CY Liu, et al.. 2009 A population-based, cases-control study of green tea consumption and leukemia risk in southwestern Taiwan Cancer Causes Control 20 57 65 10.1007/s10552-008-9217-7 10.1007/s10552-008-9217-7 18752033
5. IA Siddiqui VM Adhami DJ Bharali, et al.. 2009 Introducing nanochemoprevention as a novel approach for cancer control: proof of principle with green tea polyphenol epigallocatechin-3-gallate Cancer Res 69 1712 1716 10.1158/0008-5472.CAN-08-3978 10.1158/0008-5472.CAN-08-3978 1:CAS:528: DC%2BD1MXisFSrsbc%3D 19223530
6. Tang N, Wu Y, Zhou B, Wang B, Yu R (2009) Green tea, black tea consumption and risk of lung cancer: a meta-analysis. Lung Cancer 65:274-283.
7. Z Yu XL Qin YY Gu, et al.. 2008 Prodrugs of fluoro-substituted benzoates of EGC as tumor cellular proteasome inhibitors and apoptosis inducers Int J Mol Sci 9 951 961 1:CAS:528:DC%2BD1cXhtFWgurnI 19325839
8. VM Adhami IA Siddiqui S Sarfaraz, et al.. 2008 Effective prostate cancer chemopreventive intervention with green tea polyphenols in the TRAMP model depends on the stage of the disease Clin Cancer Res 15 1947 1953 10.1158/1078-0432.CCR-08-2332 10.1158/1078-0432.CCR-08-2332
9. J Xu J Wang F Deng Z Hu H Wang 2008 Green tea extract and its major component epigallocatechin gallate inhibits hepatitis B virus in vitro Antiviral Res 78 242 249 1:CAS:528:DC%2BD1cXktFClu7s%3D 18313149
10. T Nishikawa T Nakajima M Moriguchi, et al.. 2006 A green tea polyphenol, epigalocatechin-3-gallate, induces apoptosis of human hepatocelullar carcinoma, possibly through inhibition of Bcl-2 family proteins J Hepatol 44 1074 1082 10.1016/j.jhep.2005.11.045 10.1016/j.jhep.2005.11.045 1:CAS:528: DC%2BD28XksVaisb4%3D 16481065
11. G Qin P Gopalan-Kriczky J Su Y Ning PD Lotolikar 1997 Inhibition of aflatoxin B1-induced initiation of hepatocarcinogenesis in the rat by green tea Cancer Lett 112 149 154 10.1016/S0304-3835(96)04568-5 10.1016/S0304-3835(96) 04568-5 1:CAS:528:DyaK2sXpt12ltA%3D%3D 9066721 (Pubitemid 27104289)
12. G Qin Y Ning PD Lotlikar 2000 Chemoprevention of aflatoxin B1-initiated and carbon tetrachloride-promoted hepatocarcinogenesis in the rat by green tea Nutr Cancer 38 215 222 10.1207/S15327914NC382-11 10.1207/S15327914NC382-11 1:CAS:528:DC%2BD3MXmsF2hs7c%3D 11525600
13. K Sai J Kanno R Hasegawa JE Trosko T Inoue 2000 Prevention of the down-regulation of gap junctional intercellular communication by green tea in the liver of mice fed pentachlorophenol Carcinogenesis 21 1671 1676 10.1093/carcin/21.9.1671 10.1093/carcin/21.9.1671 1:CAS:528:DC%2BD3cXmsFKitr4%3D 10964098
14. R Sakata T Ueno T Nakamura M Sakamoto T Torikumura M Sata 2004 Green tea polyphenol epigallocatechin-3-gallate inhibits platelet-derived growth factor-induced proliferation of human hepatic stellate cell line LI90 J Hepatol 40 52 59 10.1016/S0168-8278(03)00477-X 10.1016/S0168-8278(03)00477-X 1:CAS:528:DC%2BD3sXps1Ogsbw%3D 14672614 (Pubitemid 38064713)
15. K Tamura D Nakae K Horiguchi, et al.. 1997 Inhibition by green tea extract of diethylnitrosamine-initiated but not choline-deficient, l-amino acid-defined diet-associated development of putative preneoplastic, glutathione S-transferase placental form-positive lesions in rat liver Jpn J Cancer Res 88 356 362 1:CAS:528:DyaK2sXivFeisLk%3D 9197526
16. Q Zhang X Tang Q Lu Z Zhang J Rao AD Le 2006 Green tea extract and (-)-epigallocatechin-3-gallate inhibit hypoxia- and serum-induced HIF-1alpha protein accumulation and VEGF expression in human cervical carcinoma and hepatoma cells Mol Cancer Ther 5 1227 1238 10.1158/1535-7163.MCT-05-0490 10.1158/1535-7163.MCT-05-0490 1:CAS:528:DC%2BD28XltVWnu7g%3D 16731755 (Pubitemid 43881315)
17. M Zhang X Zhao X Zhang CDJ Holman 2008 Possible protective effect of green tea intake on risk of adult leukemia Br J Cancer 98 168 170 10.1038/sj.bjc.6604140 10.1038/sj.bjc.6604140 1:STN:280:DC%2BD1c%2FhsVyjuw%3D%3D 18087282
18. L Patrick 1999 Hepatitis C: epidemiology and review of complementary/alternative medicine treatments Altern Med Rev 4 220 238 1:STN:280:DyaK1MzpvVyksg%3D%3D 10468647
19. J Nagano S Kono DL Preston K Mabuchi 2001 A prospective study of green tea consumption and cancer incidence, Hiroshima and Nagasaki (Japan) Cancer Causes Control 12 501 508 10.1023/A:1011297326696 10.1023/A:1011297326696 1:STN:280:DC%2BD3Mvns1Kmtg%3D%3D 11519758 (Pubitemid 32735122)
20. M Inoue I Yoshimi T Sobue S Tsugane 2005 Influence of coffee drinking on subsequent risk of hepatocellular carcinoma: a prospective study in Japan J Natl Cancer 97 293 300 1:CAS:528:DC%2BD2MXhsFSnsrY%3D
21. T Shimazu Y Tsubono S Kuriyama, et al.. 2005 Coffee consumption and the risk of primary liver cancer: pooled analysis of two prospective studies in Japan Int J Cancer 116 150 154 10.1002/ijc.20989 10.1002/ijc.20989 1:CAS:528:DC%2BD2MXls1KjtL8%3D 15756689 (Pubitemid 40827769)
22. N Kikuchi K Ohmori T Shimazu, et al.. 2006 No association between green tea and prostate cancer risk in Japanese men: the Ohsaki cohort study Br J Cancer 95 371 373 10.1038/sj.bjc.6603230 10.1038/sj.bjc.6603230 1:CAS:528:DC%2BD28Xnsl2iu70%3D 16804523 (Pubitemid 44187600)
23. S Kuriyama T Shimazu K Ohmori, et al.. 2006 Green tea consumption and mortality due to cardiovascular disease, cancer, and all causes in Japan: the Ohsaki study JAMA 296 1255 1265 10.1001/jama.296.10.1255 10.1001/jama.296.10. 1255 1:CAS:528:DC%2BD28Xps1GmsL8%3D 16968850 (Pubitemid 44394897)
24. I Tsuji Y Nishino T Ohkubo, et al.. 1998 A prospective cohort study on National Health Insurance beneficiaries in Ohsaki, Miyagi Prefecture, Japan: study design, profiles of the subjects and medical cost during the first year J Epidemiol 8 258 263 1:STN:280:DyaK1M7gtVaisA%3D%3D 9884474
25. K Ogawa Y Tsubono Y Nishino, et al.. 2003 Validation of a food-frequency questionnaire for cohort studies in rural Japan Public Health Nutr 6 147 157 10.1079/PHN2002411 10.1079/PHN2002411 12675957 (Pubitemid 36542431)
26. Nishino Y, Tsubono Y, Tsuji I, Hisamichi S, Yasuda T (2002) Japan, Miyagi prefecture. In: Parkin DM, Whelan SL, Ferlay J, Teppo L, Thomas DB (eds) Cancer incidence in five continents, vol 8. Lyon: IARC:260-1,716
27. JM Genkinger EA Platz SC Hoffman GW Comstock KJ Helzlsouer 2004 Fruit, vegetable, and antioxidant intake and all-cause, cancer, and cardiovascular disease mortality in a community-dwelling population in Washington County, Maryland Am J Epidemiol 160 1223 1233 15583375
28. G Fattovich F Bortolotti F Donato 2008 Natural history of chronic hepatitis B: special emphasis on disease progression and prognostic factors J Hepatol 48 335 352 10.1016/j.jhep.2007.11.011 10.1016/j.jhep.2007.11.011 18096267
29. J Tanaka J Kumagai K Katayama, et al.. 2004 Sex- and age- specific carriers of hepatitis B and C viruses in Japan estimated by the prevalence in the 3, 485, 648 first-time blood donors during 1995-2000 Intervirology 47 32 40 10.1159/000076640 10.1159/000076640 15044834 (Pubitemid 38420865)